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Latent tuberculosis (TB) bacilli: Yes or no to preventive
chemotherapyDespite extensive investigation over several decades, the
mechanism by whichMycobacterium tuberculosis establishes la-
tent infection remains poorly understood. In the latent infec-
tion, bacilli typically replicate inside host macrophages until
an effective immune response is mounted and the bacilli
become restricted to the characteristic tuberculous lesions
and the progression of the disease is halted [1]. This remarkable
feature may occur after an initial exposure to M. tuberculosis or
may happen in tuberculosis (TB) patients who thoroughly
followed the antibiotics treatment, but developed late
reactivation. To date, investigators have proposed different
views regarding the physiological states of latent TB. While
the outcome of clinical trials with isoniazid (INH) postulated
some metabolic activity for latent TB bacilli [2], the in vitro
studies suggested a metabolically inactive state for bacteria
[3]. In addition, some evidences suggest bacterial infectivity
during latency. In contrast, microscopic examination of
these tissues sometimes fails to reveal acid-fast bacilli—the
characteristic bacterial forms associated with active,
infectious TB [4].
To resolve this paradox, a few investigators proposed the
entrance of latent bacilli into an altered developmental
state in which they are no longer acid-fast. The othersFig. 1 – The viable, non-culturable, non-acid fast latent bacilli usuggested that latent bacilli remain acid-fast, but are pres-
ent in such low numbers that they defy microscopic detec-
tion [5]. Recently, the sequential adaptations of latent TB
bacilli using the in vitro gradual oxygen depletion model
(Wayne model) were documented [6]. The adaptation was
reported from 1 to 48 months post latency using Atomic
Force Microscopy (AFM). Overall, two types of latent TB bacilli,
i.e., viable culturable, acid-fast cells and viable non-culturable
and non-acid-fast bacilli were visible under AFM. As shown
in Fig. 1, these filterable and non-acid fast bacilli are too
small (150–300 lm in size) to be detected by routine
techniques. However, their passage into mice model could
induce active TB. Therefore, the latent TB bacilli may be
considered as a two-phase microorganism which needs
effective bactericidal drug(s) against its both metabolic
active and inactive states.
Today, one third of the world population, i.e., 1.7 billion
people have latent TB infection. These individuals constitute
a major obstacle for the TB control program, and the efforts to
eradicate TB must not solely rely on attacking the actively
growing tubercle bacilli, but must also include bacilli in the
latent stages. In other words, this research supports preven-
tive chemotherapy.nder Atomic Force Microscopy (AFM).
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